LET'S RETURN THE SMILE TO THE CHILDREN, THE BEAUTY TO THE WOMAN AND THE CONFIDENCE IN LIFE TO MEN
Contents of this page
Placental Histotherapy CenterThe Placentaria Histotherapy Center with an experience of more than 20 years in the treatment of foreigners with dermatological conditions, has attended more than 4000 patients in the last 5 years. In this institution the patient will find a multidisciplinary team led by the Cuban researcher Prof. Dr. Carlos Miyares Cao will provide the most specialized care in the world on conditions such as: vitiligo, psoriasis and alopecia.
With medications extracted from the human placenta, 84% of patients with Vitiligo and 78% of the Psoriasis carriers achieved the solution of their disease. In this Clinic specialized in dermatological disorders you will find the cure, the care and training of medical personnel in the aforementioned diseases, as well as postgraduate courses and exclusive medicines in the world for it.
The successful use in our country of this substance in the treatment of the dermatological disease known as Vitiligo determined that in the years 80-82 the placenta exports to France were suspended when the National Pharmaceutical Industry started the production of the new drug known asMelagenin for distribution in pharmacies by prescription.
In 1985 the first international service for Vitiligo was created in the Central Clinic "Cira Garcia" in Havana City run by Dr. Carlos Miyares Cao. Patients from countries close to Cuba (Mexico, Venezuela, Colombia, etc.) were so numerous that the first health tourism system was established.
In 1986, as a consequence of the international repercussion originated by the new Cuban treatment against vitiligo thanks to the medicine obtained from human placenta, the Council of State founded the Center for Placental Histotherapy under the direction of Dr. Carlos Miyares Cao with the objective of expanding this research.
In 1987, given the increase in the number of patients with vitiligo seeking care in Cuba with the new drug, the national and international clinical service for the treatment of this disease was created.
Medical coverage starts to be provided to patients from more than 90 countries, as well as to those affected by this disease at home.
The medical staff of these Centers received training at the Placental Histotherapy Center to ensure that the application of the method achieved the same effectiveness as in Cuba.
From 1992 to 1994, the country's management assessed the need to build a plant to obtain various medicines from human placenta, not only Melagenin, because the research developed by Dr. Carlos Miyares Cao and his team at the Placental Histotherapy Center had managed to obtain useful medicines for other pathologies and a line of highly effective cosmetics to slow the process of cellular aging.
Before the plant came into operation, Melagenin, Piloactive Lotion and Placenta Shampoo were produced in facilities of the medical-pharmaceutical industry, with separate processing, packaging and quality control units, which made it difficult to increase and produce them on a large scale, While Choriodermin and the remaining cosmetics were produced in the research area of the Histotherapy Center with better technological conditions but with scarce production capacity, making it increasingly difficult to meet the growing national and international demand for these placenta derivatives.
This situation originated the need for a plant with modern technology and high production capacity, which began its construction in 1991, in the municipality of La Lisa, near the town of Valle Grande in Havana City, in charge of the ECOA-25 of the MICONS with a project directly attended by the Investment Directorate of the Council of State.
Construction lasted 4 years, the investment area comprises 26,000 square meters and consists mainly of two parallel buildings.
The main building houses the equipment necessary for the storage and thawing of placentas collected in the country's maternity wards; extraction and bioprocessing of the different placental derivatives mentioned above, as well as their packaging and storage for subsequent distribution in the country or export.
The second building houses the Quality Control, Chemical, Microbiological and Biological laboratories and an area for the development of new technologies.
The approved workforce is 170 workers and its theoretical production capacity is 3,000 bottles per hour.
Placental Histotherapy Center